V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009599 | 270005686 | 0 | null | Curative (C) | 2013-04-01 | 2013-04-06 | OXALIPLATIN | 02 | N | 270019645 | CHLORAMBUCIL |
| 270009600 | 270005686 | 1.8 | 89.3 | Palliative (P) | 2013-12-15 | 2013-12-16 | Cetuximab 14 day | 02 | N | 270019645 | CAPECITABINE + IRINOTECAN |
| 270009601 | 270005687 | 1.72 | null | null | 2014-10-31 | 2014-11-24 | CETUXIMAB + RT | N | Y | 270019660 | CARBOPLATIN |
| 270009602 | 270005688 | 1.63 | 65 | Curative (C) | 2013-03-10 | 2013-04-03 | CAP + RT | N | null | 270019669 | GEMCARBO |
| 270009603 | 270005689 | 0 | 58 | Curative (C) | 2017-10-26 | 2017-11-17 | Carboplatin AUC 2 - 5 | N | N | 270019672 | CETUXIMAB + RT |
| 270009604 | 270005689 | 1.68 | 101 | Curative (C) | 2013-08-27 | 2013-09-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270019672 | CETUXIMAB + RT |
| 270009605 | 270005690 | 1.43 | null | Palliative (P) | null | 2018-02-11 | Carboplatin + Pemetrexed | null | null | 270019704 | CETUXIMAB + CISPLATIN + FU |
| 270009606 | 270012809 | 1.73 | 119 | Neo-adjuvant (N) | 2014-07-10 | 2014-07-26 | Carboplatin AUC 6 - 10 | 02 | N | 270019709 | ABIRATERONE |
| 270009607 | 270005691 | 1.71 | 52.5 | Palliative (P) | 2016-05-13 | 2016-05-15 | Cetuximab + FOLFIRI cycle1 | N | N | 270019712 | CETUXIMAB + IRINOTECAN + MDG |
| 270009608 | 270005692 | 1.76 | 55 | Palliative (P) | 2016-10-11 | 2016-10-24 | CISPLATIN + VINORELBINE | N | N | 270019714 | CARBOPLATIN + DOCETAXEL |
| 270009609 | 270005692 | 1.77 | 55.3 | Palliative (P) | 2015-07-28 | 2015-08-07 | Capecitabine (14 day) + Irinotecan | 02 | N | 270019714 | GEMCITABINE + NAB-PACLITAXEL |
| 270009610 | 270016019 | 1.8 | 78.75 | Curative (C) | 2016-05-28 | 2016-12-15 | Carboplatin + Docetaxel | 02 | N | 270019718 | CETUXIMAB + IRINOTECAN + MDG |
| 270009611 | 270005693 | 1.66 | 76 | Disease modification (D) | 2014-11-20 | 2014-11-27 | Brentuximab | N | N | 270019721 | VINBLASTINE |
| 270009612 | 270005694 | 1.8 | 85 | Curative (C) | 2015-11-05 | 2015-11-10 | Docetaxel 75mg/m2 (21 day) | N | N | 270019728 | FLUOROURACIL + RT |
| 270009613 | 270005695 | 1.65 | 51.1 | null | 2016-03-01 | 2016-03-02 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | 270019742 | ENZALUTAMIDE |
| 270009614 | 270005696 | 0 | null | Palliative (P) | 2016-01-07 | 2016-01-30 | Carboplatin AUC 6 - 10 | N | N | 270019743 | SCOT TRIAL |
| 270009615 | 270005697 | null | null | Palliative (P) | 2015-11-02 | 2015-11-09 | CETUXIMAB + IRINOTECAN | 02 | N | 270019753 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009616 | 270005698 | null | null | Curative (C) | null | 2015-07-07 | CVP R | N | null | 270019755 | CVP R |
| 270009617 | 270005699 | 1.84 | 100 | null | 2014-05-09 | 2014-05-16 | Carboplatin AUC 6 - 10 | 2 | N | 270019757 | CETUXIMAB + RT |
| 270009618 | 270005699 | 1.57 | 55 | Adjuvant (A) | 2018-09-12 | 2018-09-17 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 270019757 | OXALIPLATIN + RALTITREXED |
| 270009619 | 270016020 | 1.65 | 87.5 | Palliative (P) | 2019-02-13 | 2019-02-20 | CETUXIMAB + RT | 2 | N | 270019782 | CARBOPLATIN + ETOPOSIDE |
| 270009620 | 270016020 | 1.77 | null | Not known (9) | 2016-07-31 | 2016-07-31 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 270019782 | CAPECITABINE + IRINOTECAN |
| 270009621 | 270016020 | 1.61 | 93.8 | Neo-adjuvant (N) | 2014-01-19 | 2015-11-13 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 270019782 | CETUXIMAB + RT |
| 270009622 | 270005700 | 1.52 | 67 | null | 2015-06-05 | 2015-06-06 | Cetuximab + FOLFIRI cycle 2 onwards | Y | N | 270019813 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009623 | 270005700 | 1.74 | 66.8 | Adjuvant (A) | 2015-12-08 | 2015-12-29 | SCOT TRIAL | N | Y | 270019813 | CARBOPLATIN + RT |
| 270009624 | 270005701 | 1.65 | 50 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-10 | Cetuximab + Radiotherapy Load | N | N | 270019820 | CETUXIMAB + RT |
| 270009625 | 270005701 | 1.78 | 61.6 | Disease modification (D) | 2015-11-03 | 2015-11-29 | Folfirinox | N | N | 270019820 | IRINOTECAN + MDG + PANITUMUMAB |
| 270009626 | 270005702 | null | 86.8 | Palliative (P) | 2013-07-19 | 2013-07-19 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 270019825 | CAPECITABINE + IRINOTECAN |
| 270009627 | 270005703 | 1.71 | 113 | Palliative (P) | 2015-08-17 | 2015-09-06 | Bevacizumab 7.5mg/kg | N | N | 270019828 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009628 | 270005703 | null | null | Palliative (P) | 2014-12-10 | 2014-12-27 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | 270019828 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009629 | 270005704 | 1.7 | 31 | null | 2015-04-20 | 2015-04-23 | CUFOX TRIAL | N | N | 270019844 | FOXFIRE TRIAL |
| 270009630 | 270005705 | 1.78 | 79.8 | Adjuvant (A) | 2017-08-17 | 2017-08-16 | CARBOPLATIN + RT | N | N | 270019847 | IMATINIB |
| 270009631 | 270005705 | 1.73 | 81.8 | Palliative (P) | 2016-04-08 | 2016-04-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270019847 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270009632 | 270005705 | 1.59 | 77.4 | null | 2013-12-19 | 2014-01-14 | Carboplatin + Pemetrexed | N | Y | 270019847 | CETUXIMAB + RT |
| 270009633 | 270005705 | 1.74 | null | Curative (C) | null | 2016-12-12 | Carboplatin + Vinorelbine Oral | N | N | 270019847 | CARBOPLATIN |
| 270009634 | 270018886 | 1.72 | null | Adjuvant (A) | 2014-12-23 | 2014-12-24 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | 270019882 | CISPLATIN + FLUOROURACIL + RT |
| 270009635 | 270018886 | 1.72 | 25.6 | null | 2016-07-10 | 2016-07-13 | Bevacizumab + Cape + Oxali 21day | 02 | null | 270019882 | CAPECITABINE + IRINOTECAN |
| 270009636 | 270018886 | 1.8 | 106 | Neo-adjuvant (N) | 2016-04-10 | 2016-04-13 | Cetuximab + Radiotherapy Maint | 02 | N | 270019882 | CARBOPLATIN + CETUXIMAB + FU |
| 270009637 | 270018886 | 1.58 | 59 | Palliative (P) | null | 2014-10-31 | NIVOLUMAB | N | N | 270019882 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009638 | 270018886 | 0 | 66 | Adjuvant (A) | 2013-10-21 | 2013-10-22 | CETUXIMAB + RT | 02 | null | 270019882 | CVP R |
| 270009639 | 270018886 | 1.8 | 98 | Palliative (P) | 2014-04-11 | 2014-04-14 | GemCarbo Days 1+8 | N | N | 270019882 | CARBOPLATIN |
| 270009640 | 270018886 | null | null | Neo-adjuvant (N) | 2014-10-19 | 2014-10-29 | Cetuximab + Radiotherapy Load | N | Y | 270019882 | CETUXIMAB |
| 270009641 | 270005706 | 1.63 | 62 | Palliative (P) | 2014-10-25 | 2014-10-27 | Carboplatin AUC 2 - 5 | 02 | N | 270019901 | CARBOPLATIN |
| 270009642 | 270012816 | 1.66 | 61.6 | Neo-adjuvant (N) | 2016-05-28 | 2016-05-31 | CETUXIMAB | 02 | N | 270019902 | CARBOPLATIN + RT |
| 270009643 | 270005707 | 1.67 | 58.4 | Palliative (P) | 2018-07-22 | 2018-07-25 | ECX | Y | N | 270019907 | CARBOPLATIN + ETOPOSIDE |
| 270009644 | 270005707 | 1.7 | 40 | Adjuvant (A) | 2017-03-31 | 2017-03-31 | GemCarbo Days 1+8 | N | N | 270019907 | CISPLATIN + FLUOROURACIL + RT |
| 270009645 | 270005708 | 1.71 | 65 | Curative (C) | 2016-03-05 | 2016-03-06 | CAP + RT | N | Y | 270019920 | CETUXIMAB + RT |
| 270009646 | 270005708 | 1.71 | 74 | Neo-adjuvant (N) | 2014-06-21 | 2014-06-28 | CETUXIMAB | 99 | null | 270019920 | CARBOPLATIN + RT |
| 270009647 | 270005708 | 1.53 | 65.2 | Curative (C) | 2013-02-14 | 2013-03-14 | Cetuximab + Radiotherapy Load | N | Y | 270019920 | FLUOROURACIL + RT |
| 270009648 | 270005709 | null | 61.7 | Curative (C) | 2018-01-11 | 2018-01-11 | CHOP | N | N | 270019938 | NOT MATCHED |